Funding for this research was provided by:
Department of Biotechnology, Government of West Bengal (BT/PR4112/MED/12/654/2014)
Department of Health Research/Indian Council of Medical Research (GIA/31(ii)/2014-DHR)
Received: 29 October 2018
Accepted: 22 January 2019
First Online: 14 February 2019
Ethics approval and consent to participate
: The given study has been approved by the institutional ethics committee [FRIGE’s Institute of Human Genetics] with approval number FRIGE/IEC/14/2016 dated 19 November 2016. This process is in accordance with the declaration of Helsinki. An informed consent for investigation and publication of their clinical details and/or clinical images was obtained from the patient or an accompanying guardian at the time of enrolment for the study [This was in accordance with the requirement of the institutional ethics committee].
: Informed written consent was obtained from all the participants or the accompanying guardian for publication of the participants’ clinical details and/or clinical images. A copy of the written consent is available for review by the editor of this journal.
: Dr. Ashwin Dalal is a member of the editorial board (Associate Editor) of the journal BMC Medical Genetics. The authors declare that they have no competing interests (financial or non-financial) in the present study.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.